RRAM
BIO icon

River Road Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

River Road Asset Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-65,978
Closed -$9.94M – 164
2015
Q2 		$9.94M Sell
65,978
-48,470
-42% -$6.93M 0.15% 119
2015
Q1 		$15.5M Buy
114,448
+2,080
+2% +$258K 0.21% 100
2014
Q4 		$13.5M Buy
112,368
+5,947
+6% +$684K 0.19% 109
2014
Q3 		$12.1M Sell
106,421
-9,902
-9% -$1.17M 0.17% 117
2014
Q2 		$13.9M Buy
+116,323
New +$14.2M 0.18% 117

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

River Road Asset Management's BIO Position: Q3 2015 in Review

River Road Asset Management sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2015, closing a stake of 65,978 shares — an estimated $9.94M sold.

River Road Asset Management first reported a position in BIO in Q2 2014 and held it in 5 quarters. The position peaked at $15.5M in Q1 2015. 244 funds tracked by Wall St. Rank hold BIO as of Q3 2015.

  • River Road Asset Management reported no remaining Bio-Rad Laboratories Class A position as of Q3 2015 after selling out during the quarter.
  • River Road Asset Management sold 65,978 Bio-Rad Laboratories Class A shares in Q3 2015, an estimated $9.94M.
  • River Road Asset Management first reported a position in Bio-Rad Laboratories Class A in Q2 2014 and held it in 5 quarters.
  • River Road Asset Management's Bio-Rad Laboratories Class A position peaked at $15.5M in Q1 2015.
  • 244 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2015.

Based on River Road Asset Management's 13F filing for Q3 2015, filed 13 Nov 2015.